Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,202 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07568951Recruiting
Hip Muscle Strength Study in Parkinson's Disease
This study compares how hip muscles work in people with and without Parkinson's disease. Researchers will measure your hip muscle strength and control to better understand how Parkinson's affects movement and balance.
TaoyuanAges 20–85 - NCT07575334Recruiting
Acupuncture for sudden hearing loss
This trial tests whether acupuncture can help restore hearing in people who suddenly lost hearing in one ear within the past few days. If you've had sudden unexplained hearing loss, this study may help determine if acupuncture is an effective treatment.
ShanghaiAges 18–70 - NCT07577232Recruiting
Ultrasound imaging for diagnosing throat abscesses
This trial tests whether using ultrasound (sound wave imaging) through the mouth helps doctors better diagnose a throat abscess—a pocket of infection near the tonsil. The goal is to see if this imaging method improves diagnosis accuracy and treatment decisions.
CopenhagenAges 18 years+ - NCT07572669RecruitingPhase 2
Moxibustion for Steroid-Resistant Graft-Versus-Host Disease
This trial tests whether moxibustion—a traditional Chinese medicine technique using heat from burning mugwort—can help treat acute graft-versus-host disease (a complication after bone marrow transplant) that hasn't responded to steroid drugs. If you've had a stem cell transplant and developed this condition that won't go away with standard treatment, this study may be for you.
Wuhan, HubeiAges 14–65 - NCT07574515Recruiting
Nasogastric Tube for Small Bowel Blockages
This trial tests whether placing a thin feeding tube through the nose into the stomach helps reduce complications in patients with small bowel obstruction (a blockage in the small intestines). Researchers want to see if this tube improves outcomes and reduces symptoms like nausea and vomiting.
LinköpingAges 18 years+ - NCT07575009RecruitingPhase 3
Home-based continuous antibiotic infusion for children
This study tests whether children can safely receive antibiotics continuously through a pump at home instead of in the hospital. The goal is to help children recover while staying with their family and avoiding prolonged hospital stays.
TampereAges Up to 16 years - NCT07573579Recruiting
Personalised heart mapping for ventricular tachycardia treatment
This trial tests a new way of mapping the heart's electrical activity during a procedure called catheter ablation, which aims to treat a fast heart rhythm problem called ventricular tachycardia (VT). The hope is that this personalised approach will make the procedure more effective in stopping these abnormal rhythms.
LiverpoolAges 18–85 - NCT07570563RecruitingPhase 1/Phase 2
T Cell Immunotherapy for Advanced Cancers
This study tests a new immunotherapy using specially engineered immune cells (called TCR-enhanced Vδ2 T cells) to treat blood cancers or solid tumors that haven't responded to standard treatments. The goal is to see if these cells can safely shrink tumors and improve survival.
Beijing, Beijing MunicipalityAges 18–75 - NCT07570745RecruitingPhase 2
Stem cell transplant with new drugs to prevent GVHD
This trial tests a combination of medications given before and after a stem cell transplant from a family member to prevent graft-versus-host disease (GVHD)—a condition where the new cells attack your body. The study includes a newer drug called ivarmacitinib that may help reduce this serious side effect.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07571096Recruiting
PCOS and Blood Clotting Risk Assessment Study
This study helps doctors better understand polycystic ovary syndrome (PCOS)—a hormonal condition affecting ovulation—and how it relates to blood clotting problems. Researchers will collect blood samples and health information to create a risk assessment tool.
Guangzhou, GuangdongAges 14–45 - NCT07575373Recruiting
Improving Hospital Care for People With Substance Use Disorders
This study tests a new team-based approach to help hospitalized patients with substance use disorders get better care and smoother transitions when leaving the hospital. Researchers want to see if coordinated support from doctors, counselors, and social workers can improve your health outcomes and connection to treatment.
Salt Lake City, UtahAges 18 years+ - NCT07568626Recruiting
Understanding Hospital Stays After Endoscopy Procedures
This study looks at why some older patients need to stay in the hospital longer after a common digestive procedure called ERCP. Researchers want to understand the factors that affect recovery time, which may help improve care for future patients.
Xiamen, FujianAges 65 years+ - NCT07574346RecruitingEarly Phase 1
IASO207 injection for relapsed or resistant B-cell lymphoma
This early-stage trial tests IASO207, a new injection designed to treat B-cell lymphomas (blood cancers) that have come back or stopped responding to standard treatments. The drug targets a protein called CD19 found on cancer cells.
BeijingAges 18–75 - NCT07572864RecruitingPhase 2
Immunotherapy and vaccine before surgery for head and neck cancer
This trial tests a new combination of immunotherapy (a drug that helps your immune system fight cancer) and a mitochondrial vaccine given before surgery for head and neck squamous cell carcinoma. The goal is to help reduce cancer recurrence and improve survival after surgery.
Chengdu, SichuanAges 18 years+ - NCT06728956Recruiting
Online resilience training to help people with MS keep their jobs
This trial tests an online program based on Acceptance and Commitment Therapy (ACT) to build resilience and prevent job loss in people with multiple sclerosis (MS) and in healthcare workers who treat MS patients. The study will see if the program helps you stay at work and feel better.
LeedsAges 18–66 - NCT06597539Recruiting
PET scan to monitor immunotherapy in advanced liver cancer
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working in people with advanced liver or bile duct cancer. The goal is to find a better way to monitor treatment response.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06614777Recruiting
Darier's disease immune and microbiome study
This study looks at immune markers and gut/skin bacteria in people with Darier's disease. It aims to better understand the condition, which could lead to better treatments in the future.
Toulouse, Centre Hospitalier Universitaire de ToulouseAges 18 years+ - NCT06601010Recruiting
PET scan to monitor immunotherapy in pancreatic cancer
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06644274Recruiting
PET scan for tracking immunotherapy in gastrointestinal cancers
This trial uses a special PET scan called 68Ga-grazytracer to see how well immunotherapy is working in people with stomach, colon, or other gastrointestinal cancers. The goal is to find out if this scan can help doctors track your response to treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06712186RecruitingPhase 1/Phase 2
Dexmedetomidine for safer intubation in high blood pressure patients
This study tests if dexmedetomidine can help prevent dangerous blood pressure spikes during breathing tube placement for surgery in patients with high blood pressure. It is for older adults (over 60) who have been managing their hypertension for at least 6 months.
Karachi, SindhAges 60 years+ - NCT06675825Recruiting
New cap for expanding narrow esophagus in kids
This trial tests a new cap that helps doctors widen a narrowed part of the esophagus (the tube that carries food from the mouth to the stomach) in children. The cap is used during a scope procedure to make the dilation safer and easier.
RomeAges birth–18 years - NCT06728527Recruiting
Partial breast reconstruction with chest wall flap
This trial tests a specific type of partial breast reconstruction called a chest wall perforator flap. It's for women who previously had a lumpectomy and now want to improve the shape of their breast.
Cambridge, CambridgeshireAges 18 years+ - NCT06728189RecruitingPhase 1
CD70-targeted CAR-NKT cells for advanced solid tumors
This trial tests a new type of immune cell therapy (CAR-NKT cells) that targets a protein called CD70 on cancer cells. It is for people with advanced solid tumors that have not responded to at least two prior treatments.
BeijingAges 18–75 - NCT03394417Recruiting
StrataXRT skin gel to prevent rash during head and neck radiation
This trial tests whether a medicated skin gel (StrataXRT) can better prevent painful skin rash (“acute dermatitis”) in people with head and neck cancer who receive chemotherapy and radiation at the same time. If you’re eligible, you may get the study skin product and help doctors find a safer, more comfortable way to protect the skin during treatment.
SingaporeAges 21–80
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,202 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.